ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

244
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
08 Aug 2020 05:45

Asia Short Interest Weekly: SMIC, Hua Hong, WuXi, Alibaba, HSBC, Seven&I, Shimano, Kirin, Genius

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
364 Views
Share
06 Aug 2020 14:57

Tigermed IPO: Trading Debut

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
405 Views
Share
bullishWuXi AppTec
28 Jul 2020 21:02

Wuxi Apptec (药明康德) Placement: Well-Flagged Deal in the Hot Sector

Wuxi Apptec launched a USD 950 million placement after it obtained CSRC approval for its proposed A+H placement today after market close. We have...

Logo
442 Views
Share
27 Jul 2020 15:34

Tigermed (泰格医疗) A+H: Past A+H Listings Suggest Upside Might Be Limited

Tigermed, the largest China-based clinical CRO company, launched book building today to raise up to USD 1.4 bn to list in Hong Kong.  In our...

Logo
387 Views
Share
27 Jul 2020 14:38

Tigermed IPO: Valuation Insights

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
412 Views
Share
x